About BioQ Pharma
BioQ Pharma is a company based in United States founded in 2003. BioQ Pharma has raised $84.58 million across 11 funding rounds from investors including IIG PLC, Madryn Asset Management and Military Health. The company has 15 employees as of December 31, 2020. BioQ Pharma offers products and services including invenious™ Platform, Ropivacaine ReadyfusOR®, and invenious™/propofol. BioQ Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Insulet, Neurocrine and PTC Therapeutics, among others.
- Headquarter United States
- Employees 15 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioq Pharma, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$84.58 M (USD)
in 11 rounds
-
Latest Funding Round
$4.64 M (USD), Series D
Jan 10, 2020
-
Investors
IIG PLC
& 2 more
-
Employee Count
15
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioQ Pharma
BioQ Pharma offers a comprehensive portfolio of products and services, including invenious™ Platform, Ropivacaine ReadyfusOR®, and invenious™/propofol.
Transforms infusible medicines into ready-to-use systems for safer administration.
Provides tailored delivery for the Ropivacaine drug.
Offers connect-and-go solution for propofol administration.
People of BioQ Pharma
Unlock access to complete
Funding Insights of BioQ Pharma
BioQ Pharma has successfully raised a total of $84.58M across 11 strategic funding rounds. The most recent funding activity was a Series D round of $4.64 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioQ Pharma
BioQ Pharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include IIG PLC, Madryn Asset Management and Military Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by IIG toward life sciences startups.
|
Locked | Locked | Locked | |
|
Diversified asset management is provided by the firm.
|
Locked | Locked | Locked | |
|
Administers health care and support for military personnel and operations.
|
Locked | Locked | Locked |
Investor details for BioQ Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioQ Pharma
Investment portfolio details for BioQ Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioQ Pharma
Detailed financials for BioQ Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioq Pharma Comparisons
Peer comparison for BioQ Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioQ Pharma
BioQ Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Insulet, Neurocrine and PTC Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
Wearable insulin infusion systems are developed for diabetes patients.
|
|
| Locked | Locked | Locked |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| Locked | Locked | Locked |
Small molecule drugs for rare diseases are developed.
|
|
| Locked | Locked | Locked |
Therapies for neurological and neuropsychiatric diseases are developed.
|
Detailed competitors of BioQ Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioq Pharma
Complete news archive for BioQ Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioQ Pharma
BioQ Pharma was founded in 2003 and raised its 1st funding round 1 year after it was founded.
BioQ Pharma is headquartered in United States.
BioQ Pharma is a funded company, having raised a total of $84.58M across 11 funding rounds to date.
As of Dec 31, 2020, the latest employee count at BioQ Pharma is 15.
BioQ Pharmanbsp;(formerly known as BioQuiddity)nbsp;is a late-stage specialty pharmaceutical company focused onnbsp;the portfolio of large volume ready-to-use infusible pharmaceuticals using its infusion platform. The platform includes a unit dose of the drug, delivery system and administration line in one self-contained and ready-to-use presentation.nbsp;Its lead products include Ropivacaine (approved in EU) and Propofol for post-surgical pain and anesthesia. Additionally, it has four products in the development stage for sedation, antibiotics and oncology.
BioQ Pharma's top competitors include Jazz Pharmaceuticals, Insulet and PTC Therapeutics.
BioQ Pharma offers invenious™ Platform, Ropivacaine ReadyfusOR®, and invenious™/propofol.
BioQ Pharma has 3 investors. Key investors include IIG PLC, Madryn Asset Management, and Military Health.